Sartorius AG · XETR:SRT
Sartorius — Investor Presentation (August 2015)
11 slides from Sartorius's investor presentation, August 2015
Slide 1: Company Presentation
Company Presentation August 2015 1
Slide 2: Sartorius in 2014
Sartorius in 2014 Sales revenue €891.2mn Earnings1 €186.6mn Employees 5.600 Investments €80.9mn Listed since 1990, Sartorius shares Part of German TecDAX Market capitalization2 ~€ 1,9 bn Figures as of December 31, 2014; 1 Underlying EBITDA 2 excluding own shares, as of January 30, 2015
Slide 3: Global Player with Around 50 Sales and Production Sites
Global Player with Around 50 Sales and Production Sites Bohemia, New York, USA Aubagne, France Goettingen, Germany Kajaani, Finland Americas EMEA Asia | Pacific ~29% ~49% ~22% Sales share in 2014 Yauco, Puerto Rico Mohamdia, Tunisia Bangalore, India Beijing, China Figures as of December 31, 2014
Slide 4: More than 5,600 Employees Worldwide
More than 5,600 Employees Worldwide Employees Employees by Regions growth 2009-2014 EMEA ~4,350 Asia | Pacific ~17% ~70% 2009 ~5,600 ~13% Employees ~+30% Americas ~5,600 2014
Slide 5: Core Technology of Lab Division Goes Back to 1870
Core Technology of Lab Division Goes Back to 1870 Florenz Sartorius Analytical balances Sartorius plant around 1930
Slide 6: Membrane Filtration a Mainstay of Bioprocess Division Since 1927
Membrane Filtration a Mainstay of Bioprocess Division Since 1927 Richard Zsigmondy Membrane as a filter material Commercialization of the “membrane filter method“
Slide 7: Business Development Spanning More than 140 Years
Business Development Spanning More than 140 Years 2007: Merger of the BT Division with Stedim; 1870: The precision machine 1960s: Subsidiaries Sartorius Stedim Biotech is founded workshop “Feinmechanische are established in Europe 2011: Positioned as a laboratory supplier; Werkstatt” is founded by a
Slide 8: Two Divisions Sartorius Group
Two Divisions Sartorius Group Bioprocess Solutions Lab Products & Services 69 % 31 % of sales of sales revenue revenue Innovative single-use products and equipment Premium lab instruments, consumables for the manufacture of biologics and services for R&D, QA and QC Figures as of 12/31/2014
Slide 9: Bioprocess Solutions: focuses on the production of Biopharmaceuticals
Bioprocess Solutions: focuses on the production of Biopharmaceuticals Supplier of the Biopharma Industry and Pharmaindustry Under the worldwide Top 3 for important product categories Broadest portfolio of the branch Sales Revenue 615,6 Mio. €; EBITDA Margin 23,7 % Figures as of 12/31/2014 9
Slide 10: Lab Products & Services: premium Portfolio for research and quality control laboratories
Lab Products & Services: premium Portfolio for research and quality control laboratories Customer focus: Pharma, Academia, Food & Beverage, Chemical Industry 60% Instruments; 40% Consumables & Service Worldwide under the Top 4 in important product categories Sales revenue 275,5 Mio. €; EBITD
Slide 11: 11
11